Key Events This Week
8 June: Stock opens at Rs.2,086.45, down 3.58% amid market pressure
9 June: Valuation shifts to attractive despite price dip
11 June: Intraday high of Rs.2,278.45 with 7.77% surge
12 June: Week closes at Rs.2,209.50, up 0.42% on the day

RPG Life Sciences Ltd Surges 7.77% to Day's High of Rs 2278.45 — Outperforms Sector by 6.49 Percentage Points
2026-06-11 09:51:26The Sensex declined by 0.31% on 11 Jun 2026, while RPG Life Sciences Ltd surged 7.77%, marking a notable 6.49-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a three-day winning streak, accumulating an 8.21% return in that period.
Read full news article
RPG Life Sciences Ltd Valuation Shifts to Attractive Amid Market Pressure
2026-06-09 08:00:09RPG Life Sciences Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent share price declines. This change comes amid broader sector challenges and a mixed performance relative to peers, highlighting a potential opportunity for investors seeking value in the Pharmaceuticals & Biotechnology space.
Read full news article
RPG Life Sciences Ltd is Rated Sell
2026-06-03 10:10:03RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
RPG Life Sciences Ltd Faces Mildly Bearish Momentum Amid Mixed Technical Signals
2026-06-01 08:01:41RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which present a mixed but cautious outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read full news article
RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-29 08:02:00RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a recent upgrade in technical outlook, the company’s Mojo Grade was downgraded from Hold to Sell on 11 May 2026, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators.
Read full news article
RPG Life Sciences Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals
2026-05-27 08:01:56RPG Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals and moving averages suggest caution, reflected in the company’s downgrade from Hold to Sell by MarketsMOJO on 11 May 2026.
Read full news article







